REQUEST A DEMO
Total
USD $0.00
Search more companies

Vivanta Generics S.R.O. (Czech Republic)

Main Activities: Outpatient Care Centers
Full name: Vivanta Generics S.R.O. Profile Updated: December 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Vivanta Generics S.R.O. is a company in Czech Republic, with a head office in Prague. The company operates in the Outpatient Care Centers industry. It was first established on October 09, 2015. From the latest financial highlights, Vivanta Generics S.R.O. reported a net sales revenue increase of 41.95% in 2023. Its’ total assets recorded a growth of 101.31%. The net profit margin of Vivanta Generics S.R.O. increased by 25.63% in 2023.

Headquarters
Trtinova 260/1
Prague; The City of Prague; Postal Code: 19600

Contact Details: Purchase the Vivanta Generics S.R.O. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Vivanta Generics S.R.O. report to view the information.
Registered Capital:
Purchase the Vivanta Generics S.R.O. report to view the information.
Incorporation Date:
October 09, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Vivanta Generics S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
41.95%
Total operating revenue
41.95%
Operating profit (EBIT)
76.41%
EBITDA
27.28%
Net Profit (Loss) for the Period
67.81%
Total assets
101.31%
Total equity
-128.71%
Operating Profit Margin (ROS)
26.92%
Net Profit Margin
25.63%
Return on Equity (ROE)
-343.58%
Quick Ratio
0.14%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?